Asset Publisher

Proteins that protect against joint inflammation identified

Proteins that protect against joint inflammation identified

"Endogenous proteins that play a vital part in allergies and parasitic infection can prevent the immune system from wrongly attacking the body and causing inflamed joints, a study by CMM researchers published in the scientific journal PNAS reports. The researchers hope that the results will give rise to new drugs for rheumatoid arthritis.

From left to right: Zsolt Kasza, Sudeepta Kumar Panda, Long Jiang, Fredrik Wermeling, Sanjay Boddul, Yunbing Shen and Vaishnavi Iyer 

In protecting us against infections, our immune systems are vital to our survival. Unfortunately, immune cells can sometimes wrongly attack the body, resulting in what are called autoimmune diseases. These diseases are often serious and affect some five per cent of the population. One example is rheumatoid arthritis, in which the patient’s immune system attacks the joints, causing inflammation and pain. If scientists are to develop better treatments for such patients, they need to understand in detail how immune cells are regulated.

Can prevent autoimmune attacks

Researchers at CMM have now discovered that certain proteins called IL-4 and IL-13 can play an important part in preventing autoimmune attacks. The proteins, which are secreted by immune cells in the presence of allergens or parasitic infections, influence the behaviour of a specific type of immune cell called a neutrophil. Neutrophils are commonly the most abundant immune cells found in the actively inflamed joints of patients with rheumatoid arthritis. They are particularly virulent against tissue since they can secrete various fairly non-specific tissue irritants.

Previous research has shown that IL-4 and IL-13 can affect arthritis in experimental models, but exactly how they do so has remained a mystery. The results of this latest study show that these proteins prevent neutrophils from migrating into the inflamed joint. The presence of IL-4 or IL-13 also stimulates an increase in neutrophil surface receptors which have an inhibiting effect on joint inflammation.

“We will continue to study these mechanisms and hope that our work can contribute to the development of treatments for rheumatoid arthritis,” says principal investigator Fredrik Wermeling, assistant professor at the Department of Medicine, Karolinska Institutet (Solna).

Used the CRISPR method

For their study, the researchers used the CRISPR method to modify selected immune-cell genes in order to understand how they affect cell behaviour. The use of the bacterial CRISPR system as a research method is one of the most significant scientific advances of the past decade.

“The results we obtained using CRISPR were key to quickly understanding how the system under study is regulated,” says Dr Wermeling. “I have high hopes that the experimental use of CRISPR will be hugely important to our understanding of how immune-cell behaviour is regulated, and that this can guide us in the development of new efficacious drugs.”

 

Please read more at the Karolinska Institute here

 

Publication

 IL-4 controls activated neutrophil FcγR2b expression and migration into inflamed joints. Sudeepta Kumar Panda, Gustaf Wigerblad, Long Jiang, Yanek Jiménez-Andrade, Vaishnavi Srinivasan Iyer, Yunbing Shen, Sanjaykumar V. Boddul, André Ortlieb Guerreiro-Cacais, Bruno Raposo, Zsolt Kasza och Fredrik Wermeling. PNAS, online 20 January 2020, doi: 10.1073/pnas.1914186117.

NEWS

Swedish Cancer Society Grants

Swedish Cancer Society Grants From left to right: Fredrik Wermeling, Carmen Gerlach, Alexander Espinosa, Ning Xu Landén. Missing: Roland Nilsson. Photos: Private (Fredrik...

Grants from the Swedish Research Council

Grants from the Swedish Research Council We congratulate the CMMers who have recently received grants from the Swedish Research Council (Vetenskapsrådet).   Within the category of...

New Molecular Insights into Disease Exacerbation in Multiple Sclerosis

New Molecular Insights into Disease Exacerbation in Multiple Sclerosis Importance of the Atg7 gene for the recovery from inflammation in the central nervous system Multiple...

Grant from Forte to Xia Jiang

Grant from Forte to Xia Jiang Xia Jiang, Assistant Professor in Ingrid Kockum’s Group at CMM, is one of the 11 researchers from Karolinska Institutet who received research grants as a part...

Improved Patient Classification in Chronic Lymphocytic Leukemia

Improved Patient Classification in Chronic Lymphocytic Leukemia CMM Group Leader Professor Richard Rosenquist Brandell, is one of the main coauthors of a large study recently published in ...

Finding Molecular Links between Stress and Depression

Finding Molecular Links between Stress and Depression Vasco Sousa, researcher in Per Svenningson’s Group at CMM, is the first author of a study with the title “P11 deficiency increases...

Nanna Svartz Scholarship for Outstanding Research in Rheumatology 2020

Nanna Svartz Scholarship for Outstanding Research in Rheumatology 2020 The Nanna Svartz scholarship for outstanding research in rheumatology 2020 is awarded to Marie Wahren-Herlenius,...

Susanna Brauner Awarded the Swedish Society of Medicine's Translational Research Prize

Susanna Brauner Awarded the Swedish Society of Medicine's Translational Research Prize Susanna Brauner , Assistant professor and CMM researcher (Fredrik Piehl’s Team) has received the...

Ning Xu Landén 2020 Year’s Winner of the LEO Foundation Award

Ning Xu Landén 2020 Year’s Winner of the LEO Foundation Award Associate Professor Ning Xu Landén, Group Leader at CMM is the winner of this year’s LEO Foundation Award in Region EMEA...

Nils Landegren receives ERC Starting Grant for studying sex differences in the human immune system

Nils Landegren receives ERC Starting Grant for studying sex differences in the human immune system Photo: Hans Ericksson, SSMF Nils Landegren , Researcher at CMM, has been awarded...